Evidence map›Paper›PMID 33673545›Full record

ArticleInternational journal of environmental research and public health2021

Geospatial Analysis of COVID-19: A Scoping Review.

Munazza Fatima, Kara J O'Keefe, Wenjia Wei, Sana Arshad, Oliver Gruebner

Open access · goldAbstract readScoping Review
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 3 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 3 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Methods Used in the Spatial and Spatiotemporal Analysis of COVID-19 Epidemiology: A Systematic Review.International journal of environmental research and public health · 2022
    Pooled it
  4. Article
  5. [Geography and health-the example of the COVID-19 pandemic in Bremen].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Article
  6. Geospatial Genomics: Operationalizing Multilevel Conceptual Frameworks of Cancer Health Outcomes to Account for Gene-Person-Place Relationships.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  7. Spatial Analysis of Tuberculosis, COVID-19, and Tuberculosis/COVID-19 Coinfection in Recife, PE, Brazil.International journal of environmental research and public health · 2025
    Article
  8. Article
  9. Geo-Temporal Variation in the Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Munazza FatimaDepartment of Geography, The Islamia University of Bahawalpur, Punjab 63100, Pakistan.
Kara J O'KeefeDepartment of Epidemiology, Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, CH-8001 Zürich, Switzerland.
Wenjia WeiDepartment of Epidemiology, Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, CH-8001 Zürich, Switzerland.
Sana ArshadDepartment of Geography, The Islamia University of Bahawalpur, Punjab 63100, Pakistan.ORCID 0000-0003-4809-5742
Oliver GruebnerDepartment of Epidemiology, Epidemiology, Biostatistics, and Prevention Institute, University of Zurich, CH-8001 Zürich, Switzerland.ORCID 0000-0001-9783-4770
University of Zurich · CHIslamia University of Bahawalpur · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of SARS-CoV-2 in Wuhan, China in late December 2019 became the harbinger of the COVID-19 pandemic. During the pandemic, geospatial techniques, such as modeling and mapping, have helped in disease pattern detection. Here we provide a synthesis of the techniques and associated findings in relation to COVID-19 and its geographic, environmental, and socio-demographic characteristics, following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) methodology for scoping reviews. We searched PubMed for relevant articles and discussed the results separately for three categories: disease mapping, exposure mapping, and spatial epidemiological modeling. The majority of studies were ecological in nature and primarily carried out in China, Brazil, and the USA. The most common spatial methods used were clustering, hotspot analysis, space-time scan statistic, and regression modeling. Researchers used a wide range of spatial and statistical software to apply spatial analysis for the purpose of disease mapping, exposure mapping, and epidemiological modeling. Factors limiting the use of these spatial techniques were the unavailability and bias of COVID-19 data-along with scarcity of fine-scaled demographic, environmental, and socio-economic data-which restrained most of the researchers from exploring causal relationships of potential influencing factors of COVID-19. Our review identified geospatial analysis in COVID-19 research and highlighted current trends and research gaps. Since most of the studies found centered on Asia and the Americas, there is a need for more comparable spatial studies using geographically fine-scaled data in other areas of the world.

Indexed as

Geography, MedicalPandemicsBrazilChinaCOVID-19HumansSpatial AnalysisUnited StatesCOVID-19disease mappingexposure mappinghealth geographyspatial analysisspatial epidemiology

Identifiers

PMID33673545
PMCPMC7956835
OpenAlexW3135577252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.